|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Fludarabine plus cyclophosphamide and rituximab in Waldenstrom macroglobulinemia:an effective but myelosuppressive regimen to be offered to patients with advanced disease显示文摘 | Tedeschi A Benevolo G Varettoni M | 2012 | Cancer2012，118，2： | 1 |
| 2 | Incidence, presenting features and outcome of extrameduUary disease in multiple myeloma: a lon- gitudinal study on 1003 consecutive patients显示文摘 | Varettoni M Corso A Pica G | 2010 | Ann Oncol2010，21，2： | 1 |
| 3 | Incidence, presenting features and outcome of extramedullary disease in multi- pie myeloma:a longitudina study on 1003 consecutive pa- tients显示文摘 | Varettoni M Corso A Pica G | 2010 | Ann Onco2010，21，2： | 1 |
| 4 | A striking response to bortezomib in a patient with pleural localization of multiple myeloma 显示文摘 | Manqiaeavalli S Varettoni M Zappasodi P | 2009 | Leukemia Research2009，33，4： | 1 |
| 5 | Fludarabine plus cyclophosphamide and rituximab in Waldenstrom macroglobulinemia:an effective but myelosuppressive regimen to be offered to patients with advanced disease显示文摘 | Tedeschi A Benevolo G Varettoni M | 2012 | Cancer2012，118，2： | 1 |
| 6 | Incidence, presenting features and outcome of extramedullary disease in multiple myeloma: a longitudinal study on 1003 consecutive patients 显示文摘 | Varettoni M Corso A Pica G | 2010 | Ann Oncol2010，21，2： | 1 |
| 7 | Incidence, presenting features and outcome of extramedullary disease in multiple myeloma: a longitudinal study on 1003 consecutive patients显示文摘 | Varettoni M Corso A Pica G et al | 2010 | Ann Oncol2010，21，2： | 1 |
| 8 | A different sched- ule of zoledronic acid can reduce the r/sk of the osteonecro- sis of the jaw in patients with multiple myeloma 显示文摘 | Corso A Varettoni M Zappasodi P | 2007 | Leukemia2007，21，7： | 1 |
| 9 | Bortezomib plus dexametha-sone is highly effective in relapsed and refractory myeloma patients butresponses are short-lived显示文摘 | Corso A Varettoni M Mangiacavalli S e? al | 2009 | Eur J Haematol2009，83，5： | 1 |
| 10 | Inci- dence, presenting features and outcome of extramedul- lary disease in multiple myeloma: a longitudinal study on 1003 consecutive patients 显示文摘 | VARETTONI M CORSO A PICA G | 2010 | Ann Oncol2010，21，2： | 1 |
| 11 | Incidence, presentingfeatures and outcome of extramedullary disease in multiplemyeloma: A longitudinal study on 1,003 consecutivepatients显示文摘 | Varettoni M Corso A Pica G | 2009 | Ann Oncol2009，21，2： | 1 |
| 12 | Incidence,presenting features and outcome of extramedullary disease in multiple myeloma:a longitudinal study on 1003 consecutive patients显示文摘 | Varettoni M Corso A Pica G | | 0，，： | 1 |
| 13 | Prevalence and clinical significance of the MYD88 L265P somatic mutation in patients with Waldenstrom macroglobulinemia,IgM monoclonal gammopathy of undetermined significance or other mature B-cell neoplasms显示文摘 | Varettoni M Arcaini L Zibellini S | 2012 | {H}Blood2012，，： | 1 |
| 14 | Incidence, presenting fea- tures and outcome of extramedullary disease in multiple myeloma : a longitudinal study on 1003 consecutive patients 显示文摘 | Varettoni M Corse A Pica G | 2010 | Ann On- col2010，21，2： | 1 |
| 15 | Fludarabine plus eyclophosphamide and rituximab in Waldenstrom macroglobulinemia: an effective but myelosuppressive regimen to be offered to patients with advanced disease 显示文摘 | Tedeschi A Benevolo G Varettoni M | 2012 | Cancer2012，118，2： | 1 |
| 16 | Incidence, presentingfeatures and outcomes of extramedullary disease in multiplemyeloma: a longitudinal study on 1003 consecutive patients显示文摘 | Varettoni M Corso A Pica G | 2010 | Ann Oncol2010，21，2： | 1 |
| 17 | Incidence, presenting features and outcome of extramedullary disease in multiple myeloma : a longitudinal study on 1003 consecutive patients 显示文摘 | VARETTONI M CORSO A PICA G | 2010 | Ann Oncol2010，21，2： | 1 |
| 18 | Incidence,presentingfeatures and outcome of extramedullary disease in multi-ple myeloma : a longitudinal study on 1003 consecutive pa-tients 显示文摘 | Varettoni M Corso A Pica G | 2010 | Ann Oncol2010，21，2： | 1 |
| 19 | Bortezomib-induced peripheral neuropathy in multiple myeloma: A comparison between previously treated and untreated patients 显示文摘 | CORSO A MANGIACAVALLI S VARETTONI M | 2010 | Leuk Res2010，34，： | 1 |
| 20 | Efficacy of bortezomib therapy for extramedullary relapse of myeloma after autologous and non-myeloablative allogeneic transplantation显示文摘 | Varettoni M Mangiacavalli S Zappasodi P | 2008 | Leuk Res2008，32，5： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员